JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 26 July 2005. doi:10.1136/jnnp.2005.064600
Journal of Neurology, Neurosurgery, and Psychiatry 2006;77:327-333
Copyright © 2006 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jnnp.2005.064600v1
77/3/327    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gray, L J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gray, L J
Topic Collections
Right arrowRelevant Article

PAPER

Significant variation in mortality and functional outcome after acute ischaemic stroke between western countries: data from the tinzaparin in acute ischaemic stroke trial (TAIST)

L J Gray1, N Sprigg1, P M W Bath1, P Sørensen2, E Lindenstrøm2, G Boysen3, P P De Deyn4, P Friis5, D Leys6, R Marttila7, J-E Olsson8, D O’Neill9, B Ringelstein10, J-J van der Sande11, A G G Turpie12 for the TAIST Investigators

1 Institute of Neuroscience, University of Nottingham, Nottingham, UK
2 Leo Pharma A/S, Ballerup, Denmark
3 Department of Neurology, Bispebjerg Hospital, Copenhagen, Denmark
4 Department of Neurology, University of Antwerp, Antwerp, Belgium
5 Vest-Agder Sentralsykehus, Kristiansand, Norway
6 Clinique Neurologique, CHRU de Lille, Lille, France
7 Department of Neurology, Turku University Central Hospital, Turku, Finland
8 Institute for Neurology, Universitetssjukhuset, Linköping, Sweden
9 Department of Age Related Health Care, Adelaide and Meath Hospital, Dublin, Ireland
10 Neurology Clinic, Universität Münster, Münster, Germany
11 Slotervaartziekenhuis, Amsterdam, Netherlands
12 Hamilton General Hospital, Hamilton, Canada

Correspondence to:
Correspondence to:
Professor Philip Bath
Division of Stroke Medicine, University of Nottingham, D Floor, South Block, Queen’s Medical Centre, Nottingham NG7 2UH, UK; philip.bath{at}nottingham.ac.uk

Background: The medical care of patients with acute stroke varies considerably between countries. This could lead to measurable differences in mortality and functional outcome.

Objective: To compare case mix, clinical management, and functional outcome in stroke between 11 countries.

Methods: All 1484 patients from 11 countries who were enrolled into the tinzaparin in acute ischaemic stroke trial (TAIST) were included in this substudy. Information collected prospectively on demographics, risk factors, clinical features, measures of service quality (for example, admission to a stroke unit), and outcome were assessed. Outcomes were adjusted for treatment assignment, case mix, and service relative to the British Isles.

Results: Differences in case mix (mostly minor) and clinical service (many of prognostic relevance) were present between the countries. Significant differences in outcome were present between the countries. When assessed by geographical region, death or dependency were lower in North America (odds ratio (OR) adjusted for treatment group only = 0.52 (95% confidence interval, 0.39 to 0.71) and north west Europe (OR = 0.54 (0.37 to 0.78)) relative to the British Isles; similar reductions were found when adjustments were made for 11 case mix variables and five service quality measures. Similarly, case fatality rates were lower in North America (OR = 0.44 (0.30 to 0.66)) and Scandinavia (OR = 0.50 (0.33 to 0.74)) relative to the British Isles, whether crude or adjusted for case mix and service quality.

Conclusions: Both functional outcome and case fatality vary considerably between countries, even when adjusted for prognostic case mix variables and measures of good stroke care. Differing health care systems and the management of patients with acute stroke may contribute to these findings.


Keywords: case mix; country; outcome; service quality; stroke


Relevant Article

National variations in mortality and functional outcome: should we be worried?
D W J Dippel
J. Neurol. Neurosurg. Psychiatry 2006 77: 288. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Emerg. Med. J.Home page
M O McCarron, M Armstrong, and P McCarron
Potential for quality improvement of acute stroke management in a district general hospital
Emerg. Med. J., May 1, 2008; 25(5): 270 - 273.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
H. Markus
Improving the outcome of stroke
BMJ, August 25, 2007; 335(7616): 359 - 360.
[Full Text] [PDF]


Home page
Qual Saf Health CareHome page
M O McCarron, M Armstrong, and P McCarron
Effect of European working time directive on a stroke unit
Qual. Saf. Health Care, December 1, 2006; 15(6): 445 - 446.
[Full Text] [PDF]


Home page
J. Epidemiol. Community HealthHome page
G. Hughes
Hygieia
J. Epidemiol. Community Health, August 1, 2006; 60(8): 736 - 736.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
D W J Dippel
National variations in mortality and functional outcome: should we be worried?
J. Neurol. Neurosurg. Psychiatry, March 1, 2006; 77(3): 288 - 288.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd.